HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Pain and Sensory Changes Assessment in HIV+ Patients
This document reports the completion of a clinical trial evaluating pain and sensory changes in HIV-infected patients, with results posted i…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Improving Immunogenicity of Influenza Vaccine in HIV Infected Individuals [Phase 4]
This ClinicalTrials.gov update reports Phase 4 results on improving the immunogenicity of an influenza vaccine in people living with HIV; th…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT) [Phase 3]
Phase 3 open-label trial comparing telaprevir added to pegylated interferon and ribavirin versus pegylated interferon and ribavirin alone in…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) [Phase 2]
Phase 2 trial investigating telmisartan to reduce fibrotic and inflammatory contributors in HIV-1 infection has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Adherence Connection for Counseling, Education, and Support [NA]
An update on the NYU-sponsored clinical trial Adherence Connection for Counseling, Education, and Support for HIV infection. The current sta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Treatment Advocacy Intervention for HIV-Positive African Americans [NA]
This clinical trial update reports results from a completed study evaluating a treatment advocacy intervention for HIV-positive African Amer…
-
FDA approval · 2017-04-10FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for RETROVIR (zidovudine) submitted by ViiV Healthcare Company. The approval pertains to the supplem…
-
FDA approval · 2017-04-10FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for RETROVIR (zidovudine) submitted by ViiV Healthcare Company.
-
FDA approval · 2017-04-10FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for RETROVIR (zidovudine) submitted by ViiV Healthcare Company.
-
FDA approval · 2017-04-10FDA Approved: COMBIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Combivir (lamivudine and zidovudine) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Assisted Partner Notification to Augment HIV Treatment and Prevention in Kenya [NA]
Completed clinical trial in Kenya evaluating whether assisted partner notification can augment HIV treatment uptake and HIV prevention.
-
FDA approval · 2017-04-07FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) from Gilead Sciences, Inc.
-
FDA approval · 2017-04-07FDA Approved: COMPLERA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for COMPLERA, a fixed-dose combination therapy for HIV-1 infection developed by Gilead Sciences.
-
FDA approval · 2017-04-07FDA Approved: STRIBILD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for STRIBILD, a fixed-dose combination HIV-1 therapy from Gilead Sciences.
-
FDA approval · 2017-04-07FDA Approved: ODEFSEY — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for ODEFSEY (emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide) from Gilead Sc…
-
FDA approval · 2017-04-07FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for EMTRIVA (emtricitabine) from Gilead Sciences.
-
FDA approval · 2017-04-07FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for EMTRIVA (emtricitabine) from Gilead Sciences, Inc.
-
FDA approval · 2017-04-07FDA Approved: DESCOVY — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for DESCOVY (emtricitabine and tenofovir alafenamide) from Gilead Sciences, Inc.
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: An Internet-based Behavioral Weight Loss Program for HIV+ Patients [NA]
This is a completed clinical trial evaluating an Internet-based behavioral weight loss program for HIV-positive individuals. The study targe…
-
CLINICAL_TRIALS research · 2017-04-06Clinical Trial Update: An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc
This entry describes an expanded access protocol for subjects who completed clinical studies involving Maraviroc, and notes that the trial i…
-
CLINICAL_TRIALS withdrawal · 2017-04-04Clinical Trial Update: A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection [Phase 3]
A Phase 3 randomized trial of prednisone as adjunctive therapy for hospitalized patients with pulmonary tuberculosis and HIV co-infection wa…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals [Phase 1]
Phase 1 trial evaluating the antiemetic aprepitant (Emend) in HIV-infected individuals has completed, reporting preliminary safety and pharm…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
This clinical trial update reports the results of an observational study examining fat loss (lipodystrophy) in HIV-infected adults treated w…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Pre-Exposure Prophylaxis in YMSM [Phase 2]
Phase 2 study of pre-exposure prophylaxis for HIV prevention in young men who have sex with men has completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Autologous Transplant in HIV Patients (BMT CTN 0803) [Phase 2]
Phase 2 trial evaluating autologous transplant in HIV-infected patients with lymphoma; completed with results posted in 2017.